3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
11
Melanoma
9
Clear-cell metastatic renal cell carcinoma
5
Neoplasm Metastasis
4
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Histiocytoma, Malignant Fibrous
2
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Uveal Melanoma
1
Interventions
Cyclophosphamide
16
fludarabine
9
venetoclax
8
Mycophenolic Acid
8
Cytarabine
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Cyclosporine
5
ruxolitinib
4
ponatinib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Etoposide
4
Daunorubicin
4
blinatumomab
3
asciminib
3
Vincristine
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Dexamethasone
3
revumenib
2
pegfilgrastim
2
nilotinib
2
ibrutinib
2
Mesna
2
Melphalan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.